Point72 Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $174M | Sell |
353,541
-83,317
| -19% | -$45.2M | 0.22% | 68 |
|
|
2025
Q4 | $253M | Buy |
436,858
+267,407
| +158% | +$151M | 0.28% | 40 |
|
|
2025
Q3 | $82.2M | Sell |
169,451
-201,889
| -54% | -$94M | 0.14% | 162 |
|
|
2025
Q2 | $151M | Buy |
371,340
+332,540
| +857% | +$139M | 0.3% | 63 |
|
|
2025
Q1 | $19.3M | Sell |
38,800
-297
| -0.8% | -$161K | 0.04% | 455 |
|
|
2024
Q4 | $20.3M | Buy |
+39,097
| New | +$21.5M | 0.04% | 442 |
|
|
2024
Q3 | – | Sell |
-336,537
| Closed | -$199M | – | 2348 |
|
|
2024
Q2 | $186M | Buy |
336,537
+296,646
| +744% | +$170M | 0.49% | 22 |
|
|
2024
Q1 | $23.2M | Sell |
39,891
-383,912
| -91% | -$215M | 0.06% | 410 |
|
|
2023
Q4 | $225M | Buy |
423,803
+423,584
| +193,417% | +$205M | 0.54% | 16 |
|
|
2023
Q3 | $111K | Sell |
219
-1,382
| -86% | -$736K | ﹤0.01% | 1940 |
|
|
2023
Q2 | $835K | Buy |
+1,601
| New | +$864K | ﹤0.01% | 1166 |
|
|
2022
Q2 | – | Sell |
-27,061
| Closed | -$16M | – | 1637 |
|
|
2022
Q1 | $16M | Sell |
27,061
-72,757
| -73% | -$41.8M | 0.06% | 380 |
|
|
2021
Q4 | $66.6M | Sell |
99,818
-153,143
| -61% | -$95.6M | 0.27% | 85 |
|
|
2021
Q3 | $145M | Buy |
252,961
+245,753
| +3,409% | +$135M | 0.63% | 22 |
|
|
2021
Q2 | $3.64M | Sell |
7,208
-12,747
| -64% | -$6.01M | 0.02% | 660 |
|
|
2021
Q1 | $9.11M | Sell |
19,955
-14,626
| -42% | -$6.98M | 0.04% | 445 |
|
|
2020
Q4 | $16.1M | Sell |
34,581
-55,044
| -61% | -$25.8M | 0.08% | 329 |
|
|
2020
Q3 | $39.6M | Buy |
89,625
+75,689
| +543% | +$31.3M | 0.2% | 128 |
|
|
2020
Q2 | $5.05M | Buy |
+13,936
| New | +$4.67M | 0.03% | 478 |
|
|
2020
Q1 | – | Sell |
-12,700
| Closed | -$4.13M | – | 1080 |
|
|
2019
Q4 | $4.13M | Buy |
+12,700
| New | +$3.85M | 0.02% | 527 |
|
|
2018
Q4 | – | Sell |
-57,300
| Closed | -$14M | – | 1205 |
|
|
2018
Q3 | $14M | Buy |
57,300
+47,300
| +473% | +$10.9M | 0.06% | 385 |
|
|
2018
Q2 | $2.07M | Sell |
10,000
-306,138
| -97% | -$65M | 0.01% | 750 |
|
|
2018
Q1 | $65.3M | Buy |
+316,138
| New | +$66.4M | 0.27% | 101 |
|
|
2017
Q4 | – | Sell |
-35,000
| Closed | -$6.62M | – | 1078 |
|
|
2017
Q3 | $6.62M | Sell |
35,000
-91,605
| -72% | -$16.6M | 0.03% | 491 |
|
|
2017
Q2 | $22.1M | Buy |
+126,605
| New | +$21.3M | 0.12% | 226 |
|
|
2017
Q1 | – | Sell |
-183,552
| Closed | -$25.9M | – | 965 |
|
|
2016
Q4 | $25.9M | Buy |
+183,552
| New | +$27.1M | 0.18% | 159 |
|
|
2016
Q1 | – | Sell |
-1,500
| Closed | -$213K | – | 848 |
|
|
2015
Q4 | $213K | Sell |
1,500
-300
| -17% | -$40K | ﹤0.01% | 648 |
|
|
2015
Q3 | $220K | Sell |
1,800
-31,500
| -95% | -$4.1M | ﹤0.01% | 684 |
|
|
2015
Q2 | $4.32M | Buy |
+33,300
| New | +$4.34M | 0.03% | 466 |
|
|
2015
Q1 | – | Sell |
-239,700
| Closed | -$30M | – | 796 |
|
|
2014
Q4 | $30M | Buy |
239,700
+159,900
| +200% | +$19.4M | 0.21% | 155 |
|
|
2014
Q3 | $9.71M | Sell |
79,800
-68,600
| -46% | -$8.34M | 0.07% | 285 |
|
|
2014
Q2 | $17.5M | Buy |
+148,400
| New | +$17.5M | 0.11% | 224 |
|
Other funds holding TMO
VCM
Point72 Asset Management's TMO Position: Q1 2026 in Review
Point72 Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, selling an estimated $45.2M and leaving 353,541 shares worth $174M. The position accounts for 0.22% of the portfolio, ranked #68.
Point72 Asset Management first reported a position in TMO in Q2 2014 and has held it in 32 quarters since. The position peaked at $253M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Point72 Asset Management held 353,541 shares of Thermo Fisher Scientific worth $174M as of Q1 2026.
- Point72 Asset Management sold 83,317 Thermo Fisher Scientific shares in Q1 2026, an estimated $45.2M.
- Thermo Fisher Scientific made up 0.22% of Point72 Asset Management's portfolio in Q1 2026, its #68 holding.
- Point72 Asset Management first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 32 quarters since.
- Point72 Asset Management's Thermo Fisher Scientific position peaked at $253M in Q4 2025.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.